![Neil Desai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil Desai
Directeur/Membre du Conseil chez
WHITEHAWK THERAPEUTICS, INC.
Fortune : 9 M $ au 31/05/2026
Profil
Neil P.
Desai is the founder of Aadi Subsidiary, Inc. since 2011, holding the title of Executive Chairman.
Current job includes Director at Whitehawk Therapeutics, Inc. since 2024.
Former jobs include Director at Mercator MedSystems, Inc., Vice President-Strategic Platforms at Celgene Corp.
from 2010 to 2016, Senior Research Scientist at American Bioscience, Inc. from 1991 to 1994, Senior VP-Global Research & Development at Abraxis BioScience, Inc. from 2008 to 2010, and Vice President-Research & Development at Abraxis BioScience, Inc. from 1999 to 2008.
Education includes graduate and doctorate degrees from The University of Texas at Austin and an undergraduate degree from the Institute of Chemical Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/04/2026 | 1 811 241 ( 3,84 % ) | 9 M $ | 31/05/2026 |
Postes actifs de Neil Desai
| Sociétés | Poste | Début |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/10/2024 |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Fondateur | 01/10/2011 |
Anciens postes connus de Neil Desai
| Sociétés | Poste | Fin |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01/10/2016 |
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/10/2010 |
Abraxis BioScience, Inc. /Old/
 Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/10/2008 |
Mercator MedSystems, Inc.
 Mercator MedSystems, Inc. Medical SpecialtiesHealth Technology Develops medical injection devices | Directeur/Membre du Conseil | - |
American Bioscience, Inc.
 American Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Directeur Technique/Scientifique/R&D | - |
Formation de Neil Desai
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
American Bioscience, Inc.
American Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mercator MedSystems, Inc.
Mercator MedSystems, Inc. Medical SpecialtiesHealth Technology Develops medical injection devices | Health Technology |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Health Technology |
Institute of Chemical Technology
 Institute of Chemical Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aadi Subsidiary, Inc.
Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
